ESMO 2018: Assessment of asymptomatic brain metastases in kidney cancer patients
The results of an analysis of renal cell carcinoma (RCC) [...]
The results of an analysis of renal cell carcinoma (RCC) [...]
Analysis of the phase 3 CheckMate-214 study has shown that [...]
Immune-related adverse events (irAEs) are side effects that can develop [...]
The European Association of Urology (EAU) Renal Cell Cancer Guidelines [...]
These short videos explain the latest results from the following [...]
Yesterday it was announced that the combination of ipilimumab and [...]
Findings from an expanded access programme giving 389 metastatic renal [...]
A recent meta-analysis evaluating the efficacy of first- and second-line [...]
The following interview with Dr Eric Jonasch, medical oncologist from [...]
Patient-reported outcomes data from the Phase 3 CheckMate-214 trial of [...]